EMEA-001627-PIP01-14-M03
EMEA-001627-PIP01-14-M03
EMEA-001627-PIP01-14-M03
Opinion/decision on a Paediatric investigation plan (PIP): Filsuvez, birch bark, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Dermatology, PIP number: P/0243/2023
Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immunology-Rheumatology-Transplantation, PIP number: P/0202/2023
EMEA-001150-PIP02-13-M05
Opinion/decision on a Paediatric investigation plan (PIP): Kyntheum, brodalumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Dermatology, PIP number: P/0212/2023
EMEA-000902-PIP01-10-M01
Opinion/decision on a Paediatric investigation plan (PIP): Ponvory, ponesimod, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neurology;Other, PIP number: P/0234/2023
EMEA-000551-PIP04-21-M02
Opinion/decision on a Paediatric investigation plan (PIP): Noxafil, posaconazole, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0200/2023
EMEA-000347-PIP02-16-M05